International Clinical Trial: NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND, SHAM-CONTROLLED CROSSOVER STUDY

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890948) titled 'NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND, SHAM-CONTROLLED CROSSOVER STUDY' on Oct. 18.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Device Feasibility. Masking: Single (Participant).

Primary Sponsor: Hoag Memorial Hospital Presbyterian

Condition: Irritable Bowel Syndrome (IBS)

Intervention: Device: Nurosym Device

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 1, 2026

Target Sample Size: 40

To know...